MEYER ANDREW HOLLMAN (Chief Business Officer) sold 2.2% of their position (1.88K shares) of JANUX THERAPEUTICS, INC. on the open market
Open‑market sale worth $25.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/2/2026ACC: 0001864159-26-000002
Officer· Chief Business Officer
Since Jun 2021
-1.88K
Net shares
Net seller
$25.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.88K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.88K
Price / share
$13.73
Trade value
$25.80K
% of position
2.2%
1/2/2026
84.97K→83.09K
Total
Net shares
−1.88K
Net value
-$25.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | S · Sale | −1.88K | $13.73 | $25.80K | 2.2% | 84.97K | 83.09K |
| Total | −1.88K | -$25.80K | ||||||
Derivative Transactions0
No derivative transactions reported